Drugs that act on the brain oxytocin (OXT) system may provide a much-needed treatment
breakthrough for substance-use disorders. Targeting the brain OXT system has the potential …

Deficits in social processing (SP) have been proposed to underpin interpersonal dysfunction
in both Borderline Personality Disorder (BPD) and Substance Use Disorders (SUD). This …

Approved pharmacological treatments for alcohol use disorder are limited in their
effectiveness, and new drugs that can easily be translated into the clinic are warranted. One …

Social interaction is closely associated with both functional capacity and well-being.
Previous research has not only revealed evidence of social dysfunction in individuals with a …

In developed countries, obesity has become an epidemic resulting in enormous health care
costs for society and serious medical complications for individuals. The homeostatic …

Introduction The subjective experience of drug craving is a prominent and common clinical
phenomenon for many individuals diagnosed with opioid use disorder (OUD), and could be …

Early life trauma is strongly associated with an increased vulnerability to abuse illicit drugs
and the impairment of neural development. This includes alterations to the development of …

Drug addiction is one of the leading causes of mortality worldwide. Despite great advances
were achieved in understanding the neurobiology of drug addiction, the therapeutic options …

Opioid addiction has devastating health and socio‐economic consequences, and current
pharmacotherapy is limited and often accompanied by side effects, thus novel treatment is …

Existing pharmacotherapies for managing craving, a strong predictor of relapse to
automated addictive behaviours, are limited in efficacy and characterised by increased …